New syndicated reports now available
May 11, 2023 | Living with, Patient reports, Syndicated
Living with CD, PsO, IPF & PF-ILD 2023
Living with Crohn’s Disease (CD) covers 4EU+UK and Japan. Living with Psoriasis (PsO) covers the 4EU+UK. Living with Idiopathic Pulmonary Fibrosis (IPF) & Progressive Fibrosing Interstitial Lung Disease (PF-ILD) covers the US, 4EU+UK and China.
These new syndicated reports are based on quantitative and qualitative market research with patients and are available to purchase. The methodologies for all reports consist of 30-minute online interviews and 40-minute qualitative tele-depth interviews with patients, including a patient-diary exercise.
The reports are designed to provide an in-depth understanding of the patient journey, from diagnosis through to ongoing management of the condition. Through these reports, you will understand how patients’ lives are impacted physically and emotionally, what impacts treatment decision-making and satisfaction, and what unmet needs patients have related to their condition.
The Living With team at Research Partnership is continually expanding the reports to cover a large range of therapy areas and markets. To find out more about other upcoming reports, request an information pack, or arrange a meeting to discuss therapy areas of interest please contact us now.
Head of Living With, Mariel Metcalfe commented, “Research Partnership is committed to producing research which focuses on the voice of the patient, and to offer a more patient-centric view of what it is like to live with a long-term, life-changing illness. Our reports cover a wide range of therapy areas from Autoimmune, Dermatology, Gastroenterology and Respiratory, and we hope to expand the list of therapy areas year on year.”
Find out more about our Living With reports here
This content was provided by Inizio
Company Details
Latest Content from Inizio
Infographic: Are data blind spots putting your launch at risk?
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult to understand market readiness, prioritize…
Key takeaways from ASCO® 2026
Following ASCO® 2026, Inizio’s experts have shared their perspectives across three thought leadership articles, each exploring a different aspect of what this year’s congress revealed for pharmaceutical organisations. Together, they…
Webcast | Smarter science, sharper strategy: Expert perspectives from ASCO® 2026
Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.
From activity to impact: 5 takeaways from MAPS Americas 2026
Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now…
Inizio launches Intelligent Congress: Turning medical event investment into measurable impact
Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize…
Inizio Unveils Next-Generation Hub Services at Asembia 2026, Setting a New Standard in Patient Access
Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence
5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you
Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercialization™. Now we’re back in the…
Precision Medical Affairs in Action: Using AI and Analytics to Elevate Strategy, Engagement, and Impact
Discover how AI, analytics and real-world data are reshaping Medical Affairs.
How did multifaceted support from across Inizio help a biotech firm prepare for launch?
Discover how teams from across Inizio provided a range of integrated services to give a client’s product the best chance of launch success.
Our key takeaways from ISMPP EU 2026 – Evolving with Purpose: Excellence in an Era of Efficiency
Explore Inizio Medical’s key takeaway from ISMPP EU 2026, including AI governance, transparency, patient partnership and evolving impact measurement.